MACQUARIE GROUP LTD - NEVRO CORP ownership

NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 215 filers reported holding NEVRO CORP in Q4 2021. The put-call ratio across all filers is 1.68 and the average weighting 0.1%.

Quarter-by-quarter ownership
MACQUARIE GROUP LTD ownership history of NEVRO CORP
ValueSharesWeighting
Q3 2022$50,000
+6.4%
604
-43.6%
0.00%
Q2 2022$47,000
-39.0%
1,0710.0%0.00%
Q1 2022$77,000
-94.8%
1,071
-94.1%
0.00%
-100.0%
Q4 2021$1,469,000
-63.6%
18,116
-47.7%
0.00%
-66.7%
Q3 2021$4,034,000
-32.8%
34,658
-4.2%
0.00%
-40.0%
Q2 2021$6,000,000
+128.0%
36,185
+91.7%
0.01%
+25.0%
Q1 2021$2,632,000
-84.9%
18,872
-81.2%
0.00%
-84.0%
Q4 2020$17,395,000
+48.9%
100,496
+19.8%
0.02%
+25.0%
Q3 2020$11,686,000
-2.1%
83,887
-16.0%
0.02%
-4.8%
Q2 2020$11,937,000
+74.1%
99,916
+45.7%
0.02%
+50.0%
Q1 2020$6,856,000
-47.9%
68,574
-38.7%
0.01%
-26.3%
Q4 2019$13,157,000
+7.5%
111,936
-21.4%
0.02%
-9.5%
Q3 2019$12,241,000
-58.7%
142,386
-68.8%
0.02%
+23.5%
Q2 2019$29,625,000
+915.3%
456,966
+1150.3%
0.02%
+240.0%
Q2 2018$2,918,000
+11.8%
36,548
+21.4%
0.01%0.0%
Q1 2018$2,610,000
+12.0%
30,111
-10.8%
0.01%
+25.0%
Q4 2017$2,331,000
+7.0%
33,760
+40.8%
0.00%0.0%
Q3 2017$2,179,000
+14.3%
23,978
-6.4%
0.00%
+33.3%
Q2 2017$1,907,000
-72.1%
25,622
-64.8%
0.00%
-75.0%
Q1 2017$6,825,000
+34.0%
72,838
+3.9%
0.01%
+20.0%
Q4 2016$5,093,000
-38.6%
70,090
-11.8%
0.01%
-37.5%
Q3 2016$8,298,000
-32.5%
79,490
-52.3%
0.02%
+33.3%
Q2 2016$12,290,000166,6180.01%
Other shareholders
NEVRO CORP shareholders Q4 2021
NameSharesValueWeighting ↓
Tiger Eye Capital LLC 239,122$41,392,0008.25%
Integral Health Asset Management, LLC 88,000$15,233,0004.53%
Iron Triangle Partners LP 168,761$29,213,0003.79%
Eos Focused Equity Management, L.P. 14,002$2,424,0002.37%
PFM Health Sciences, LP 311,940$53,997,0001.90%
Perceptive Advisors 977,565$169,217,0001.82%
Rock Springs Capital Management LP 395,000$68,375,0001.45%
Lisanti Capital Growth, LLC 54,302$9,400,0001.30%
HealthCor Management, L.P. 156,046$27,012,0001.04%
FRED ALGER MANAGEMENT, LLC 2,136,612$369,848,0000.96%
View complete list of NEVRO CORP shareholders